ArticleOncoTargets and therapy2015

Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?

Tulay Kus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.